Literature DB >> 16138954

Curative catheter ablation for atrial fibrillation.

Eric D Good1, Hakan Oral.   

Abstract

With the recent advances in the understanding of the mechanisms of atrial fibrillation, radiofrequency catheter ablation has emerged as an effective therapeutic modality for patients with atrial fibrillation. Techniques for catheter ablation evolved from elimination of triggers that often originate within the pulmonary veins and initiate atrial fibrillation, to additional left atrial ablation using a variety of approaches to also eliminate the mechanisms that play a role in perpetuation of atrial fibrillation. With the current ablation strategies, atrial fibrillation can be eliminated in approximately 85% of patients with paroxysmal, and in approximately 70% of patients with chronic, atrial fibrillation with a low incidence of significant complications. In symptomatic patients with paroxysmal or chronic atrial fibrillation who have failed antiarrhythmic drug therapy, catheter ablation is an effective treatment strategy for maintenance of sinus rhythm.

Entities:  

Year:  2005        PMID: 16138954     DOI: 10.1007/s11936-005-0019-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  38 in total

1.  Images in cardiovascular medicine. Esophageal migration during left atrial catheter ablation for atrial fibrillation.

Authors:  Jihn Han; Eric Good; Fred Morady; Hakan Oral
Journal:  Circulation       Date:  2004-12-14       Impact factor: 29.690

2.  Vein of marshall cannulation for the analysis of electrical activity in patients with focal atrial fibrillation.

Authors:  C Hwang; T J Wu; R N Doshi; C T Peter; P S Chen
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

3.  A conceptual model of atrial fibrillation.

Authors:  G K Moe
Journal:  J Electrocardiol       Date:  1968       Impact factor: 1.438

4.  Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

Authors:  M Haïssaguerre; D C Shah; P Jaïs; M Hocini; T Yamane; I Deisenhofer; M Chauvin; S Garrigue; J Clémenty
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

5.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation.

Authors:  P Jaïs; M Haïssaguerre; D C Shah; S Chouairi; L Gencel; M Hocini; J Clémenty
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

6.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

7.  Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights.

Authors:  Hakan Oral; Bradley P Knight; Mehmet Ozaydin; Aman Chugh; Steve W K Lai; Christoph Scharf; Sohail Hassan; Radmira Greenstein; Jihn D Han; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

Review 8.  Rotors and spiral waves in atrial fibrillation.

Authors:  José Jalife
Journal:  J Cardiovasc Electrophysiol       Date:  2003-07

9.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

10.  Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation.

Authors:  Athar M Qureshi; Lourdes R Prieto; Larry A Latson; Geoffrey K Lane; C Igor Mesia; Penelope Radvansky; Richard D White; Nassir F Marrouche; Eduardo B Saad; Dianna L Bash; Andrea Natale; John F Rhodes
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.